1
|
Yung M, Narayanaswami P, Pesa J, Choudhry Z, Jackson L, Deering KL, Sebaaly J, Richardson J, Feldman J, Peters W, Taylor M, Foss A, West B, Shea L, Geonnotti G, Govindarajan R. Patient and care partner perspectives and preferences related to myasthenia gravis treatment: A qualitative study. Health Sci Rep 2024; 7:e70081. [PMID: 39323457 PMCID: PMC11422664 DOI: 10.1002/hsr2.70081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2024] [Revised: 08/07/2024] [Accepted: 09/03/2024] [Indexed: 09/27/2024] Open
Abstract
Background and Aims Due to the high symptom and treatment burden in myasthenia gravis (MG), understanding patient and care partner perspectives and preferences is crucial. Methods This study used voice analysis and virtual focus groups to understand patient and care partner experiences with MG-related symptoms, treatments, and preferences. The voice analysis via social media listening used artificial intelligence-powered tools to gather and structure public digital conversations on MG. Focus groups included people living with MG and care partners who completed a questionnaire and participated in a 1-h virtual session facilitated using a semi-structured interview guide. Qualitative data were aggregated, transcribed, and thematically analyzed. Results The voice analysis examined 11,554 posts from 8321 individuals, discussing MG symptoms, treatments, and burden. Of 7563 symptom-related posts, 5902 (78%) conveyed negative, 1427 (19%) neutral, and 234 (3%) positive sentiment. The most frequently mentioned symptoms were categorized as dysarthria, muscle weakness, and dysphagia. MG treatment sentiment analysis identified 6667 posts (67%) as neutral, 2887 (29%) as negative, and 350 (4%) as positive. For the focus groups, 15 individuals (12 patients and 3 care partners) completed the questionnaire and 14 participated in the virtual focus group sessions. The 15 participants who completed the questionnaire prioritized treatment convenience, symptom control for improved quality of life, and preventing potential MG crises in their current treatment. New treatment expectations included increased effectiveness, less frequent dosing, faster onset, and fewer side effects. Participants were also receptive to wearable medication delivery systems placed on the body and valued direct involvement in treatment decisions. Conclusion Patients and care partners are often negatively impacted by MG symptoms and value convenient and fast-acting treatments that control symptoms with minimal side effects. Considering patient preferences may help optimize treatment decisions and improve patients' overall well-being and satisfaction in their care.
Collapse
Affiliation(s)
| | - Pushpa Narayanaswami
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolBostonMassachusettsUSA
| | | | - Zia Choudhry
- Janssen Scientific Affairs, LLCTitusvilleNew JerseyUSA
| | - Louis Jackson
- Janssen Scientific Affairs, LLCTitusvilleNew JerseyUSA
| | | | | | | | | | - Wesley Peters
- CorEvitas, Part of Thermo Fisher ScientificWalthamMassachusettsUSA
| | - Melina Taylor
- CorEvitas, Part of Thermo Fisher ScientificWalthamMassachusettsUSA
| | - Allison Foss
- Myasthenia Gravis AssociationKansas CityMissouriUSA
| | - Bruce West
- Patient Engagement Research Council (PERC) MemberUSA
| | - Lisa Shea
- Janssen Scientific Affairs, LLCTitusvilleNew JerseyUSA
| | | | | |
Collapse
|
2
|
Gong F, Loeb S, Siu K, Myrie A, Orstad S, Kenfield SA, Morgans A, Thakker S, Robbins R, Carter P, Jean-Louis G, Nolasco TS, Byrne N, Gupta N. Sleep disturbances are underappreciated in prostate cancer survivorship. Prostate Cancer Prostatic Dis 2023; 26:210-212. [PMID: 36543892 DOI: 10.1038/s41391-022-00630-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Revised: 11/29/2022] [Accepted: 12/02/2022] [Indexed: 12/24/2022]
Abstract
BACKGROUND The prevalence of sleep disturbances among prostate cancer (PCa) survivors, and extent of urologist involvement in sleep care are not well-studied. METHODS PCa survivors (n = 167) and urologists (n = 145) were surveyed about sleep disturbances and survivorship care practices. RESULTS Most PCa survivors had sleep disturbances, including 50.9% with poor sleep quality, 18.0% with clinical/severe insomnia, and 36.5% at high-risk for sleep apnea. Few urologists routinely screened for sleep disturbances, as recommended in national cancer survivorship guidelines. CONCLUSIONS Optimal PCa survivorship care should incorporate screening for sleep disturbances, addressing comorbid factors affecting sleep and referring to sleep medicine when appropriate.
Collapse
Affiliation(s)
- Fred Gong
- From SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
| | - Stacy Loeb
- New York University Langone Health, New York, NY, USA
- Manhattan Veterans Affairs, New York, NY, USA
| | - Katherine Siu
- New York University Langone Health, New York, NY, USA
- Manhattan Veterans Affairs, New York, NY, USA
| | | | - Stephanie Orstad
- New York University Langone Health, New York, NY, USA
- Manhattan Veterans Affairs, New York, NY, USA
| | | | - Alicia Morgans
- Dana- Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
| | | | - Rebecca Robbins
- Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Patricia Carter
- The Capstone College of Nursing, University of Alabama, Tuscaloosa, AL, USA
| | | | - Tatiana Sanchez Nolasco
- New York University Langone Health, New York, NY, USA
- Manhattan Veterans Affairs, New York, NY, USA
| | - Nataliya Byrne
- New York University Langone Health, New York, NY, USA
- Manhattan Veterans Affairs, New York, NY, USA
| | - Natasha Gupta
- New York University Langone Health, New York, NY, USA
- Manhattan Veterans Affairs, New York, NY, USA
| |
Collapse
|
3
|
Lam CS, Zhou K, Loong HHF, Chung VCH, Ngan CK, Cheung YT. The Use of Traditional, Complementary, and Integrative Medicine in Cancer: A Data-Mining Study of One-million Online Posts from Health Forums and Social Media Platforms (Preprint). J Med Internet Res 2023; 25:e45408. [PMID: 37083752 PMCID: PMC10163397 DOI: 10.2196/45408] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2023] [Revised: 02/19/2023] [Accepted: 03/12/2023] [Indexed: 03/13/2023] Open
Abstract
BACKGROUND Patients with cancer are increasingly using forums and social media platforms to access health information and share their experiences, particularly in the use of traditional, complementary, and integrative medicine (TCIM). Despite the popularity of TCIM among patients with cancer, few related studies have used data from these web-based sources to explore the use of TCIM among patients with cancer. OBJECTIVE This study leveraged multiple forums and social media platforms to explore patients' use, interest, and perception of TCIM for cancer care. METHODS Posts (in English) related to TCIM were collected from Facebook, Twitter, Reddit, and 16 health forums from inception until February 2022. Both manual assessments and natural language processing were performed. Descriptive analyses were performed to explore the most commonly discussed TCIM modalities for each symptom and cancer type. Sentiment analyses were performed to measure the polarity of each post or comment, and themes were identified from posts with positive and negative sentiments. TCIM modalities that are emerging or recommended in the guidelines were identified a priori. Exploratory topic-modeling analyses with latent Dirichlet allocation were conducted to investigate the patients' perceptions of these modalities. RESULTS Among the 1,620,755 posts available, cancer-related symptoms, such as pain (10/10, 100% cancer types), anxiety and depression (9/10, 90%), and poor sleep (9/10, 90%), were commonly discussed. Cannabis was among the most frequently discussed TCIM modalities for pain in 7 (70%) out of 10 cancer types, as well as nausea and vomiting, loss of appetite, anxiety and depression, and poor sleep. A total of 7 positive and 7 negative themes were also identified. The positive themes included TCIM, making symptoms manageable, and reducing the need for medication and their side effects. The belief that TCIM and conventional treatments were not mutually exclusive and intolerance to conventional treatment may facilitate TCIM use. Conversely, TCIM was viewed as leading to patients' refusal of conventional treatment or delays in diagnosis and treatment. Doctors' ignorance regarding TCIM and the lack of information provided about TCIM may be barriers to its use. Exploratory analyses showed that TCIM recommendations were well discussed among patients; however, these modalities were also used for many other indications. Other notable topics included concerns about the legalization of cannabis, acupressure techniques, and positive experiences of meditation. CONCLUSIONS Using machine learning techniques, social media and health forums provide a valuable resource for patient-generated data regarding the pattern of use and patients' perceptions of TCIM. Such information will help clarify patients' needs and concerns and provide directions for research on integrating TCIM into cancer care. Our results also suggest that effective communication about TCIM should be achieved and that doctors should be more open-minded to actively discuss TCIM use with their patients.
Collapse
Affiliation(s)
- Chun Sing Lam
- School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China (Hong Kong)
| | - Keary Zhou
- School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China (Hong Kong)
| | - Herbert Ho-Fung Loong
- Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China (Hong Kong)
| | - Vincent Chi-Ho Chung
- School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China (Hong Kong)
- Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China (Hong Kong)
| | - Chun-Kit Ngan
- Data Science Program, Worcester Polytechnic Institute, Worcester, MA, United States
| | - Yin Ting Cheung
- School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China (Hong Kong)
| |
Collapse
|
4
|
Miyahira AK, Soule HR. The 28th Annual Prostate Cancer Foundation Scientific Retreat report. Prostate 2022; 82:1346-1377. [PMID: 35852016 DOI: 10.1002/pros.24409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Accepted: 06/24/2022] [Indexed: 11/07/2022]
Abstract
BACKGROUND The 28th Annual Prostate Cancer Foundation (PCF) Scientific Retreat was held virtually over 4 days, on October 28-29 and November 4-5, 2021. METHODS The Annual PCF Scientific Retreat is a leading global scientific conference that focuses on first-in-field, unpublished, and high-impact basic, translational, and clinical prostate cancer research, as well as research from other fields with high probability for impacting prostate cancer research and patient care. RESULTS Primary areas of research discussed at the 2021 PCF Retreat included: (i) prostate cancer disparities; (ii) prostate cancer survivorship; (iii) next-generation precision medicine; (iv) PSMA theranostics; (v) prostate cancer lineage plasticity; (vi) tumor metabolism as a cancer driver and treatment target; (vii) prostate cancer genetics and polygenic risk scores; (viii) glucocorticoid receptor biology in castration-resistant prostate cancer (CRPC); (ix) therapeutic degraders; (x) new approaches for immunotherapy in prostate cancer; (xi) novel technologies to overcome the suppressive tumor microenvironment; and (xii) real-world evidence and synthetic/virtual control arms. CONCLUSIONS This article provides a summary of the presentations from the 2021 PCF Scientific Retreat. We hope that sharing this knowledge will help to improve the understanding of the current state of research and direct new advances in prostate cancer research and care.
Collapse
Affiliation(s)
- Andrea K Miyahira
- Science Department, Prostate Cancer Foundation, Santa Monica, California, USA
| | - Howard R Soule
- Science Department, Prostate Cancer Foundation, Santa Monica, California, USA
| |
Collapse
|
5
|
Thakker S, Robbins R, Carter P, Jean‐Louis G, Siu K, Sanchez Nolasco T, Byrne N, Orstad SL, Myrie A, Loeb S. Research communication: Poor sleep health and quality of life among caregivers of patients with prostate cancer. BJUI COMPASS 2022; 3:331-333. [PMID: 35950040 PMCID: PMC9349590 DOI: 10.1002/bco2.157] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2022] [Revised: 04/10/2022] [Accepted: 04/12/2022] [Indexed: 11/17/2022] Open
Affiliation(s)
| | - Rebecca Robbins
- Division of Sleep Medicine Harvard Medical School Boston Massachusetts USA
- Department of Medicine, Division of Sleep and Circadian Disorders Brigham & Women's Hospital Boston Massachusetts USA
| | - Patricia Carter
- Capstone College of Nursing University of Alabama Tuscaloosa Alabama USA
| | - Girardin Jean‐Louis
- Departments of Psychiatry and Neurology, Miller School of Medicine University of Miami Miami Florida USA
| | - Katherine Siu
- Departments of Urology and Population Health NYU Langone Health New York New York USA
| | | | - Nataliya Byrne
- Departments of Urology and Population Health NYU Langone Health New York New York USA
| | - Stephanie L. Orstad
- Department of Medicine, Division of General Internal Medicine and Clinical Innovation NYU Grossman School of Medicine New York New York USA
| | - Akya Myrie
- Department of Urology Cleveland Clinic Cleveland Ohio USA
| | - Stacy Loeb
- Departments of Urology and Population Health NYU Langone Health New York New York USA
| |
Collapse
|
6
|
Robbins R, Cole R, Ejikeme C, Orstad SL, Porten S, Salter CA, Sanchez Nolasco T, Vieira D, Loeb S. Systematic review of sleep and sleep disorders among prostate cancer patients and caregivers: a call to action for using validated sleep assessments during prostate cancer care. Sleep Med 2022; 94:38-53. [PMID: 35489117 PMCID: PMC9277625 DOI: 10.1016/j.sleep.2022.03.020] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/18/2022] [Revised: 03/20/2022] [Accepted: 03/24/2022] [Indexed: 12/27/2022]
Abstract
OBJECTIVE/BACKGROUND To examine the impact of prostate cancer (PCa) on sleep health for patients and caregivers. We hypothesized that sleep disturbances and poor sleep quality would be prevalent among patients with PCa and their caregivers. PATIENTS/METHODS A systematic literature search was conducted according to the Preferred Reporting Items for a Systematic Review and Meta-analysis guidelines. To be eligible for this systematic review, studies had to include: (1) patients diagnosed with PCa and/or their caregivers; and (2) objective or subjective data on sleep. 2431 articles were identified from the search. After duplicates were removed, 1577 abstracts were screened for eligibility, and 315 underwent full-text review. RESULTS AND CONCLUSIONS Overall, 83 articles met inclusion criteria and were included in the qualitative synthesis. The majority of papers included patients with PCa (98%), who varied widely in their treatment stage. Only 3 studies reported on sleep among caregivers of patients with PCa. Most studies were designed to address a different issue and examined sleep as a secondary endpoint. Commonly used instruments included the Insomnia Severity Index and European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaires (EORTC-QLQ). Overall, patients with PCa reported a variety of sleep issues, including insomnia and general sleep difficulties. Both physical and psychological barriers to sleep are reported in this population. There was common use of hypnotic medications, yet few studies of behavioral interventions to improve sleep for patients with PCa or their caregivers. Many different sleep issues are reported by patients with PCa and caregivers with diverse sleep measurement methods and surveys. Future research may develop consensus on validated sleep assessment tools for use in PCa clinical care and research to promote facilitate comparison of sleep across PCa treatment stages. Also, future research is needed on behavioral interventions to improve sleep among this population.
Collapse
Affiliation(s)
- Rebecca Robbins
- Harvard Medical School, Boston, MA, USA; Brigham & Women's Hospital, Boston, MA, USA.
| | - Renee Cole
- Department of Urology, University of Michigan, Ann Arbor, MI, USA
| | | | - Stephanie L Orstad
- Division of General Internal Medicine and Clinical Innovation, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA
| | - Sima Porten
- Department of Urology, University of California, San Francisco, USA
| | | | | | - Dorice Vieira
- NYU Grossman School of Medicine, New York, NY, USA; Department of Population Health, NYU School of Medicine, New York, NY, USA
| | - Stacy Loeb
- Departments of Urology and Population Health, NYU School of Medicine and Manhattan Veterans Affairs, New York, NY, USA
| |
Collapse
|
7
|
Loeb S, Malik R. Methodologies in Social Media Research: Where We Are and Where We Still Need to Go? JCO Oncol Pract 2022; 18:533-535. [PMID: 35500209 DOI: 10.1200/op.21.00871] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Stacy Loeb
- Department of Urology and Population Health, New York University and Manhattan Veterans Affairs, New York, NY
| | - Rena Malik
- Division of Urology, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD
| |
Collapse
|
8
|
Nabi J. The provision of comfort: addressing barriers to sleep in prostate cancer. BJU Int 2020; 125:627-628. [PMID: 32349185 DOI: 10.1111/bju.15053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Junaid Nabi
- Department of Surgery, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.,Centre for Surgery and Public Health, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA
| |
Collapse
|